| Pfizer Looks to Next-Generation Antibody-Drug Conjugates with CytomX Therapeutics Collaboration |
Abstract
|
|
Heather Cartwright |
|
| J&J’s Janssen Biotech Invests in Microbiome Research with Second Genome Collaboration |
Abstract
|
|
Heather Cartwright |
|
| Elan Strikes Series of Deals to Diversify and Stave Off Royalty Pharma |
Abstract
|
|
Heather Cartwright |
|
| Novo A/S Acquires Anti-Infectives Developer Xellia Pharmaceuticals from 3i |
Abstract
|
|
Heather Cartwright |
|
| BTG Expands Interventional Medicine Business with Acquisitions of Ekos and Nordion’s Targeted Therapies Division |
Abstract
|
|
Heather Cartwright |
|
| Valeant Aims to Compete in Ophthalmology with US$8.7 B Bausch & Lomb Buyout |
Abstract
|
|
Heather Cartwright |
|
| AstraZeneca Bolsters Late-Stage Cardiovascular Disease Pipeline with Omthera Pharmaceuticals Purchase |
Abstract
|
|
Heather Cartwright |
|
| GSK Brings Next-Generation Vaccine Technology In-House with Okairos Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Amgen to Re-Enter Japanese Market with Astellas Pharma Partnership |
Abstract
|
|
Heather Cartwright |
|
